| Synonyms: | |
| Status: | Approved (2015) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | B01AF03 |
| UNII: | NDU3J18APO |
| InChI Key | HGVDHZBSSITLCT-JLJPHGGASA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H30ClN7O4S |
| Molecular Weight | 548.07 |
| AlogP | 1.29 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 136.63 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 37.0 |
| Primary Target | |
|---|---|
| coagulation factor X |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S1A subfamily
|
- | 3-3 | - | 1 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Atrial Fibrillation | 3 | D001281 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Stroke | 3 | D020521 | ClinicalTrials |
| Aortic Valve Stenosis | 3 | D001024 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Venous Thromboembolism | 3 | D054556 | ClinicalTrials |
| Heart Diseases | 3 | D006331 | ClinicalTrials |
| Hemorrhage | 2 | D006470 | ClinicalTrials |
| Blood Coagulation Disorders | 2 | D001778 | ClinicalTrials |
| Peripheral Arterial Disease | 2 | D058729 | ClinicalTrials |
| Ischemic Stroke | 2 | D000083242 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 480449-70-5 |
| ChEBI | 85973 |
| ChEMBL | CHEMBL1269025 |
| DrugBank | DB09075 |
| DrugCentral | 4897 |
| EPA CompTox | DTXSID50197398 |
| FDA SRS | NDU3J18APO |
| Guide to Pharmacology | 7575 |
| PharmGKB | PA166128806 |
| PubChem | 10280735 |
| SureChEMBL | SCHEMBL330046 |
| ZINC | ZINC000043200832 |